Bwxt medical and northstar medical radioisotopes sign supply agreement supporting actinium-225 production

Ottawa, ontario & beloit, wis.--(business wire)---- $bwxt--bwxt medical ltd., a subsidiary of bwx technologies, inc. (nyse: bwxt) and northstar medical radioisotopes, llc (northstar) today announced that they have signed a master services agreement (msa), which will facilitate the production of actinium-225 (ac-225), a critical medical isotope used to kill cancer cells while minimizing the impact to healthy tissues. medical isotopes are essential for a wide range of diagnostic and therapeutic procedures,.
BWXT Ratings Summary
BWXT Quant Ranking